• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.35% Nasdaq Down 0.34%

    ACADIA Pharmaceuticals Inc. (ACAD)

    -NasdaqGS
    32.49 Down 0.13(0.40%) 3:18PM EDT - Nasdaq Real Time Price
    Prev Close:32.62
    Open:32.70
    Bid:32.35 x 600
    Ask:32.38 x 400
    1y Target Est:46.13
    Beta:3.8269
    Earnings Date:Nov 3 - Nov 7 (Est.)
    Day's Range:32.16 - 33.18
    52wk Range:16.64 - 43.89
    Volume:1,126,619
    Avg Vol (3m):2,267,100
    Market Cap:3.89B
    P/E (ttm):N/A
    EPS (ttm):-1.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACAD

    Comparison

    Symbol% ChgMkt Cap
    ACADDown 0.40%3.89B
    AZNDown 0.15%84.12B
    PFEDown 0.66%211.57B
    LLYDown 1.09%82.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):23,686.90
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-2.15
    Quarterly EPS Est (Sep-16) :-0.55
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-1.60

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback